The risk of malarial infections and disease in Papua New Guinean children

American Journal of Tropical Medicine and Hygiene

Volumn 76, Issue 6, 2007, Pages 997-1008

  Michon, Pascal ^a   Cole Tobian, Jennifer L ^b   Dabod, Elijah ^a   Schoepflin, Sonja ^c   Igu, Jennifer ^a   Susapu, Melinda ^a   Tarongka, Nandao ^a   Zimmerman, Peter A ^b   Reeder, John C ^a   Beeson, James G ^d   Schofield, Louis ^d   King, Christopher L ^a   Mueller, Ivo ^a  

^a PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^d WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; PROTOZOAL DNA; PROTOZOON ANTIBODY; SESQUITERPENE;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; CHILD; FEMALE; FOLLOW UP; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALARIA; MALARIA FALCIPARUM; MALE; PAPUA NEW GUINEA; PARASITEMIA; PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PLASMODIUM OVALE; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; RECURRENCE RISK; REINFECTION; RISK REDUCTION; ANIMAL; BLOOD; CHEMISTRY; GENETICS; IMMUNOLOGY; INCIDENCE; LONGITUDINAL STUDY; PRESCHOOL CHILD; RISK FACTOR; RURAL POPULATION;

PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PLASMODIUM OVALE; PLASMODIUM VIVAX;

ADOLESCENT; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; DNA, PROTOZOAN; FEMALE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALARIA, FALCIPARUM; MALARIA, VIVAX; MALE; PAPUA NEW GUINEA; PARASITEMIA; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; RISK FACTORS; RURAL POPULATION; SESQUITERPENES;

EID: 34547722599     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2007.76.997     Document Type: Article

References (50)

1. Marsh K, Kinyanjui S, 2006. Immune effector mechanisms in malaria. Parasite Immunol 28: 51-60.
2. Gupta S, Snow RW, Donnelly CA, Marsh K, Newbold C, 1999. Immunity to non-cerebral severe malaria is acquired after one or two infections. Nat Med 5: 340-343.
3. Genton B, Al Yaman F, Beck HP, Hii J, Mellor S, Narara A, Gibson N, Smith T, Alpers MP, 1995. The epidemiology of malaria in the Wosera area, East Sepik Province, Papua New Guinea, in preparation for vaccine trials. I. Malariometric indices and immunity. Ann Trop Med Parasitol 89: 359-376.
4. Genton B, Al Yaman F, Beck HP, Hn J, Mellor S, Rare L, Ginny M, Smith T, Alpers MP, 1995. The epidemiology of malaria in the Wosera area, East Sepik Province, Papua New Guinea, in preparation for vaccine trials. II. Mortality and morbidity. Ann Trop Med Parasitol 89: 377-390.
5. Schofield L, Mueller I, 2006. Clinical immunity to malaria. Curr Mol Med 6: 205-221.
6. Yazdani SS, Mukherjee P, Chauhan VS, Chitnis CE, 2006. Immune responses to asexual blood-stages of malaria parasites. Curr Mol Med 6: 187-203.
7. Wipasa J, Elliott S, Xu H, Good MF, 2002. Immunity to asexual blood stage malaria and vaccine approaches. Immunol Cell Biol 80: 401-414.
8. Bull PC, Marsh K, 2002. The role of antibodies to Plasmodium falciparum-infected-erythrocyte surface antigens in naturally acquired immunity to malaria. Trends Microbiol 10: 55-58.
9. Smith T, Hii JL, Genton B, Muller I, Booth M, Gibson N, Narara A, Alpers MP, 2001. Associations of peak shifts in age-prevalence for human malarias with bednet coverage. Trans R Soc Trop Med Hyg 95: 1-6.
10. Kasehagen LJ, Mueller I, McNamara DT, Bockarie MJ, Kiniboro B, Rare L, Lorry K, Kastens W, Reeder JC, Kazura JW, Zimmerman PA, 2006. Changing patterns of Plasmodium blood-stage infections in the Wosera region of Papua New Guinea monitored by light microscopy and high throughput PCR diagnosis. Am J Trop Med Hyg 75: 588-596.
11. Cox MJ, Kum DE, Tavul L, Narara A, Raiko A, Baisor M, Alpers MP, Medley GF, Day KP, 1994. Dynamics of malaria parasitaemia associated with febrile illness in children from a rural area of Madang, Papua New Guinea. Trans R Soc Trop Med Hyg 88: 191-197.
12. Hii JL, Smith T, Mai A, Ibam E, Alpers MP, 2000. Comparison between anopheline mosquitoes (Diptera: Culicidae) caught using different methods in a malaria endemic area of Papua New Guinea. Bull Entomol Res 90: 211-219.
13. Arevalo-Herrera M, Herrera S, 2001. Plasmodium vivax malaria vaccine development. Mol Immunol 2001: 443-455.
14. Cole-Tobian JL, Cortes A, Baisor M, Kastens W, Xainli J, Bockarie M, Adams JH, King CL, 2002. Age-acquired immunity to a Plasmodium vivax invasion ligand, the duffy binding protein. J Infect Dis 186: 531-539.
15. Michon P, Fraser T, Adams JH, 2000. Naturally acquired and vaccine-elicited antibodies block erythrocyte cytoadherence of the Plasmodium vivax Duffy binding protein. Infect Immun 68: 3164-3171.
16. Mehlotra RK, Kasehagen LJ, Baisor M, Lorry K, Kazura JW, Bockarie MJ, Zimmerman PA, 2002. Malaria infections are randomly distributed in diverse holoendemic areas of Papua New Guinea. Am J Trop Med Hyg 67: 555-562.
17. Burkot TR, Graves PM, Paru R, Wirtz RA, Heywood PF, 1988. Human malaria transmission studies in the Anopheles punctulatus complex in Papua New Guinea: sporozoite rates, inoculation rates, and sporozoite densities. Am J Trop Med Hyg 39: 135-144.
18. Belkin JN, 1962. The Mosquitoes of the South Pacific (Diptera: Culicidae). Volume 1. Berkeley, CA: University of California Press.
19. Benet A, Mai A, Bockarie F, Lagog M, Zimmerman P, Alpers MP, Reeder JC, Bockarie MJ, 2004. Polymerase chain reaction diagnosis and the changing pattern of vector ecology and malaria transmission dynamics in Papua New Guinea. Am J Trop Med Hyg 71: 277-284.
20. Wirtz RA, Burkot TR, Graves PM, Andre RG, 1987. Field evaluation of enzyme-linked immunosorbent assays for Plasmodium falciparum and Plasmodium vivax sporozoites in mosquitoes (Diptera: Culicidae) from Papua New Guinea. J Med Entomol 24: 433-437.
21. McNamara DT, Kasehagen LJ, Grimberg BT, Cole-Tobian J, Collins WE, Zimmerman PA, 2006. Diagnosing infection levels of four human malaria parasite species by a polymerase chain reaction/ligase detection reaction fluorescent microsphere-based assay. Am J Trop Med Hyg 74: 413-421.
22. McNamara DT, Thomson JM, Kasehagen LJ, Zimmerman PA, 2004. Development of a multiplex PCR-ligase detection reaction assay for diagnosis of infection by four human malaria parasite species. J. Clin. Microbol. 42: 2403-2410.
23. Felger I, Beck HP, 2002. Genotyping of Plasmodium falciparum: RFLP analysis. Methods Mol Med 72: 117-129.
24. Irion A, Felger I, Abdulla S, Smith T, Mull R, Tanner M, Hatz C, Beck HP, 1998. Distinction of recrudescences from new infections by PCR-RFLP analysis in a comparative trial of CGP 56 697 and chloroquine in Tanzanian children. Trop Med Int Health 3: 490-497.
25. Cole-Tobian J, Zimmerman PA, King CL, High throughput identification of the predominant malaria parasite clone in complex blood stage infections using a multi-SNP molecular haplotyping assay. Am J Trop Med Hyg 76: 12-19.
26. Smith T, Genton B, Baea K, Gibson N, Taime J, Narara A, Al Yaman F, Beck HP, Hii J, Alpers M, 1994. Relationships between Plasmodium falciparum infection and morbidity in a highly endemic area. Parasitology 109: 539-549.
27. Cattani JA, Tulloch JL, Vrbova H, Jolley D, Gibson FD, Moir JS, Heywood PF, Alpers MP, Stevenson A, Clancy R, 1986. The epidemiology of malaria in a population surrounding Madang, Papua New Guinea. Am J Trop Med Hyg 35: 3-15.
28. Owusu-Agyei S, Binka F, Koram K, An to F, Adjuik M, Nkrumah F, Smith T, 2002. Does radical cure of asymptomatic Plasmodium falciparum place adults in endemic areas at increased risk of recurrent symptomatic malaria? Trop Med Int Health 7: 599-603.
29. Smith T, Felger I, Tanner M, Beck HP, 1999. Premunition in Plasmodium falciparum infection: insights from the epidemiology of multiple infections. Trans R Soc Trop Med Hyg 93 (Suppl 1): 59-64.
30. Maitland K, Williams AI, Bennett NM, Newbold C, Peto TE, Viji J, Timothy R, Clegg A, Weatherall DJ, 1996. The interaction of between Plasmodium falciparum and P. vivax in children on Espiritu Santo island, Vanuatu. Trans R Soc Trop Med Hyg 90: 614-620.
31. Balfour MC, 1935. Malaria studies in Greece. Am J Trop Med Hyg 15: 301-329.
32. Earle WC, 1939. Epidemiology of malaria in Puerto Rico. Puerto Rico J Pub Health Trop Med 15: 3-27.
33. Ciuca M, Ballif L, Chelarescu-Vieru M, 1934. Immunity in Mlaria. Trans R Soc Trop Med Hyg 6: 619-622.
34. Collins WE, Jeffery GM, Roberts JM, 2004. A retrospective examination of reinfection of humans with Plasmodium vivax. Am J Trop Med Hyg 70: 642-644.
35. Collins WE, Jeffery GM, 1999. A retrospective examination of secondary sporozoite- and trophozoite-induced infections with Plasmodium falciparum: development of parasitologic and clinical immunity following secondary infection. Am J Trop Med Hyg 61: 20-35.
36. Gunewardena DM, Carter R, Mendis KN, 1994. Patterns of acquired anti-malarial immunity in Sri Lanka. Mem Inst Oswaldo Cruz 89: 63-65.
37. Muller I, Smith T, Mellor S, Rare L, Genton B, 1998. The effect of distance from home on attendance at a small rural health centre in Papua New Guinea. Int J Epidemiol 27: 878-884.
38. Oppenheimer SJ, Macfarlane SB, Moody JB, Bunari O, Williams TE, Harrison C, Hendrickse RG, 1984. Iron and infection in infancy-report on field studies in Papua New Guinea: 1. Demographic description and pilot surveys. Ann Trop Paediatr 4: 135-143.
39. Wildig J, Michon P, Siba P, Mellombo M, Ura A, Mueller I, Cossart Y, 2006. Parvovirus B19 infection contributes to severe anemia in young children in Papua New Guinea. J Infect Dis 194: 146-153.
40. McElroy PD, ter Kuile FO, Lal AA, Bioland PB, Hawley WA, Oloo AJ, Monto AS, Meshnick SR, Nahlen BL, 2000. Effect of Plasmodium falciparum parasitemia density on hemoglobin concentrations among full-term, normal birth weight children in western Kenya, IV. The Asembo Bay Cohort Project. Am J Trop Med Hyg 62: 504-512.
41. Greenwood BM, Bradley AK, Greenwood AM, Byass P, Jammeh K, Marsh K, Tulloch S, Oldfield FS, Hayes R, 1987. Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa. Trans R Soc Trop Med Hyg 81: 478-486.
42. Trape JF, Rogier C, Konate L, Diagne N, Bouganali H, Canque B, Legros F, Badji A, Ndiaye G, Ndiaye P, 1994. The Dielmo project: a longitudinal study of natural malaria infection and the mechanisms of protective immunity in a community living in a holoendemic area of Senegal. Am J Trop Med Hyg 51: 123-137.
43. Faye FB, Konate L, Rogier C, Trape JF, 1998. Plasmodium ovale in a highly malaria endemic area of Senegal. Trans R Soc Trop Med Hyg 92: 522-525.
44. Williams TN, Maitland K, Bennett S, Ganczakowski M, Peto TE, Newbold CI, Bowden DK, Weatherall DJ, Clegg JB, 1996. High incidence of malaria in alpha-thalassaemic children. Nature 383: 522-525.
45. Mayxay M, Pukrittayakamee S, Newton PN, White NJ, 2004. Mixed-species malaria infections in humans. Trends Parasitol 20: 233-240.
46. Snounou G, White NJ, 2004. The co-existence of Plasmodium: sidelights from falciparum and vivax malaria in Thailand. Trends Parasitol 20: 333-339.
47. Smith T, Genton B, Baea K, Gibson N, Narara A, Alpers MP, 2001. Prospective risk of morbidity in relation to malaria infection in an area of high endemicity of multiple species of Plasmodium. Am J Trop Med Hyg 64: 262-267.
48. McKenzie FE, Bossert WH, 1997. Mixed-species Plasmodium infections of humans. J Parasitol 83: 593-600.
49. Bruce MC, Donnelly CA, Packer M, Lagog M, Gibson N, Narara A, Walliker D, Alpers MP, Day KP, 2000. Age- and species-specific duration of infection in asymptomatic malaria infections in Papua New Guinea. Parasitology 121: 247-256.
50. Bruce MC, Galinski MR, Barnwell JW, Donnelly CA, Walmsley M, Alpers MP, Walliker D, Day KP, 2000. Genetic diversity and dynamics of Plasmodium falciparum and P. vivax populations in multiply infected children with asymptomatic malaria infections in Papua New Guinea. Parasitology 121: 257-272.